SCHEMBL23263129

SCHEMBL23263129

CC(C)(C)OC(=O)Oc1cc(-c2cncc(F)c2)cccc1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 5/20 0.39
▸ BACE2 Q9Y5Z0 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ KDR P35968 1/20 0.36
▸ CYP11B2 P19099 3/20 0.36
▸ CYP11B1 P15538 2/20 0.36
▸ DYRK1A Q13627 3/20 0.35
▸ CTPS1 P17812 2/20 0.35
▸ ABL1 P00519 2/20 0.35
▸ RPS6KB1 P23443 1/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ NTRK2 Q16620 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34
▸ CLK2 P49760 1/20 0.34
▸ FYN P06241 2/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23263168 0.87 BACE1 (0.38) BACE1BACE2PIK3CGCYP11B2CYP11B1
SCHEMBL23263201 0.86 BACE1 (0.39) BACE1KDRDYRK1A
SCHEMBL23263842 0.86 PIK3CG (0.38) BACE1PIK3CGCYP11B2CYP11B1DYRK1A
SCHEMBL23263865 0.85 ABL1 (0.37) BACE1BACE2ABL1
SCHEMBL23263133 0.85 ALOX5AP (0.44) BACE1BACE2PIK3CGKDRCYP11B2
SCHEMBL23263195 0.84 MKNK1 (0.46) CYP11B2CYP11B1DYRK1A
SCHEMBL23263181 0.82 GSK3B (0.35) KDRDYRK1ARPS6KB1CSNK1DGSK3A
SCHEMBL23263197 0.82 ABL1 (0.36) DYRK1AABL1RPS6KB1CSNK1DGSK3A
SCHEMBL23263340 0.82 KIF11 (0.43) CYP11B2CYP11B1
SCHEMBL23258871 0.80 ELANE (0.41) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
WO-2021076945-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2021-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS TXNRD2, TXNRD1, SDHB BACE1 586/4885BACE2 1736/4885PIK3CG 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback